EdgarLookup
SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company
Kymera Therapeutics, Inc.
Filed
June 1, 2022
Accession Number
0000921895-22-001863
View Document ↗ View on SEC.gov ↗